- PR Newswire•16 days ago
SAN DIEGO, Jan. 3, 2017 /PRNewswire/ -- OncoSec Medical Incorporated ("OncoSec") (NASDAQ: ONCS), a company developing DNA-based intratumoral cancer immunotherapies, announced today that members ...
- Accesswire•23 days ago
Developing DNA-based Oncology Treatments for Patients who do not Respond to Checkpoint Inhibitors; Report Available here: http://www.lifescicapital.com/equity-research/oncosec/ NEW YORK, NY / ACCESSWIRE ...
- PR Newswire•last month
SAN DIEGO, Dec. 8, 2016 /PRNewswire/ -- OncoSec Medical Incorporated ("OncoSec") (NASDAQ: ONCS), a company developing DNA-based intratumoral cancer immunotherapies, today announced financial ...
ONCS : Summary for OncoSec Medical Incorporated - Yahoo Finance
OncoSec Medical Incorporated (ONCS)
NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
|Bid||1.28 x 700|
|Ask||1.29 x 300|
|Day's Range||1.26 - 1.30|
|52 Week Range||1.19 - 3.49|
Trade prices are not sourced from all markets
|PE Ratio (TTM)||-0.79|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|